Eventide Asset Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-800,000
Closed -$6.04M 142
2020
Q1
$6.04M Sell
800,000
-3,326,131
-81% -$37.3M 0.2% 93
2019
Q4
$64M Sell
4,126,131
-568,786
-12% -$5.73M 1.8% 14
2019
Q3
$24.4M Buy
4,694,917
+409,305
+10% +$3.04M 0.81% 48
2019
Q2
$38.8M Buy
4,285,612
+1,816,591
+74% +$27.1M 1.18% 26
2019
Q1
$58.9M Buy
2,469,021
+264,313
+12% +$5.41M 2.03% 10
2018
Q4
$36.2M Buy
2,204,708
+89,708
+4% +$1.77M 1.6% 19
2018
Q3
$56.2M Buy
2,115,000
+513,339
+32% +$11.6M 2.06% 10
2018
Q2
$36.6M Buy
1,601,661
+1,028,108
+179% +$22.5M 1.52% 23
2018
Q1
$12.2M Buy
573,553
+21,453
+4% +$327K 0.57% 62
2017
Q4
$6.98M Buy
552,100
+2,100
+0.4% +$28.2K 0.36% 73
2017
Q3
$8.51M Hold
550,000
0.48% 62
2017
Q2
$6.43M Buy
550,000
+255,000
+86% +$3.16M 0.4% 64
2017
Q1
$3.46M Buy
+295,000
New +$3.38M 0.23% 82

Other funds holding MYOV

Eventide Asset Management's MYOV Position: Q2 2020 in Review

Eventide Asset Management sold out of Myovant Sciences Ltd. (MYOV) in Q2 2020, closing a stake of 800,000 shares — an estimated $6.04M sold.

Eventide Asset Management first reported a position in MYOV in Q1 2017 and held it in 13 quarters. The position peaked at $64M in Q4 2019. 96 funds tracked by Wall St. Rank hold MYOV as of Q2 2020.

  • Eventide Asset Management reported no remaining Myovant Sciences Ltd. position as of Q2 2020 after selling out during the quarter.
  • Eventide Asset Management sold 800,000 Myovant Sciences Ltd. shares in Q2 2020, an estimated $6.04M.
  • Eventide Asset Management first reported a position in Myovant Sciences Ltd. in Q1 2017 and held it in 13 quarters.
  • Eventide Asset Management's Myovant Sciences Ltd. position peaked at $64M in Q4 2019.
  • 96 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2020.

Based on Eventide Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.